https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 Prostate external beam radiotherapy combined with high-dose-rate brachytherapy: dose-volume parameters from deformably-registered plans correlate with late gastrointestinal complications https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:29346 Wed 23 Feb 2022 16:04:41 AEDT ]]> Registering prostate external beam radiotherapy with a boost from high-dose-rate brachytherapy: a comparative evaluation of deformable registration algorithms https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:25925 Wed 11 Apr 2018 14:57:01 AEST ]]> Spatial features of dose-surface maps from deformably-registered plans correlate with late gastrointestinal complications https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:31828 Wed 09 Mar 2022 16:00:57 AEDT ]]> Accumulation of rectum dose-volume metrics for prostate external beam radiotherapy combined with brachytherapy: evaluating deformably registered dose distribution addition using parameter-based addition https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:34511 0.1cc, D1cc, D2cc and D10cc were calculated in two ways. (i) Parameter-adding: the EBRT DVH parameters (or the EBRT prescription dose) were added to the unregistered HDR-BT DVH parameters. (ii) Distribution-adding: the parameters were extracted after the EBRT doses were 3D-summed with the registered HDR-BT doses. Resulting differences between the parameters were investigated. Results: The D0.1cc, D1cc and D2cc from parameter-adding were 21.3% (P < 0.001), 6.3% (P < 0.001) and 3.5% (P < 0.001) smaller than those from distribution-adding. The D10cc was 2.2% (P=0.015) larger for distribution-adding. Conclusion: Distribution-adding was confounded by unsystematic inter/intra-observer rectum-contouring errors and registration accuracy near the anterior rectal wall. Consequently, clinical use of distribution-adding to assess rectal doses requires careful contour and registration evaluation.]]> Thu 28 Oct 2021 13:04:40 AEDT ]]> Patient costs associated with external beam radiotherapy treatment for localized prostate cancer: the benefits of hypofractionated over conventionally fractionated radiotherapy https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:21446 Sat 24 Mar 2018 08:05:44 AEDT ]]> Phase 3 trial of domiciliary humidification to mitigate acute mucosal toxicity during radiation therapy for head-and-neck cancer: first report of Trans Tasman Radiation Oncology Group (TROG) 07.03 RadioHUM study https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:20970 Sat 24 Mar 2018 07:54:21 AEDT ]]> Treatment-related morbidity in prostate cancer: a comparison of 3-dimensional conformal radiation therapy with and without image guidance using implanted fiducial markers https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:20180 Sat 24 Mar 2018 07:51:39 AEDT ]]> Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:38069 Fri 12 Nov 2021 12:17:35 AEDT ]]>